ZLCS:
Analysis & Opinions
-
March 13, 2012
If you're looking for cutting-edge companies that have a chance to triple or quadruple in the coming months and ...
-
August 17, 2011
In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
